INS and Insulin resistance: GSK3 is a negative regulator of insulin signalling, strongly linked with insulin resistance and numerous studies targeting GSK3 provide compelling evidence for GSK3-inhibition improving insulin sensitivity as a therapeutic target in T2DM61–65.